NCT00881036 Activation of Hepatitis B Virus (HBV) in Hepatitis B Surface Antigen (HBsAg) - Negative But Hepatitis B Core Antibody (Anti-HBc) - Positive Patients Status COMPLETED Phase N/A
NCT00880477 Immunogenicity and Safety of Primary and Booster Vaccination With DTPa-HBV-IPV/Hib Vaccine Status COMPLETED Phase PHASE3
NCT00879827 Immunogenicity and Reactogenicity of GSK Bio DTPa-HBV-IPV and Hib Vaccines When Coadministered to Healthy Infants Status COMPLETED Phase PHASE3
NCT00877357 Safety, Long Term Immunogenicity and Lot Consistency Study of Liquid Pentavalent Combination Vaccine Status UNKNOWN Phase PHASE4
NCT00875485 Evaluation of Antibody Persistence & Immune Memory in Subjects Vaccinated During Adolescence With Twinrix™ Status COMPLETED Phase PHASE4
NCT00871741 Feasibility Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine in Healthy Infants at 3, 5 and 11 Months of Age. Status TERMINATED Phase PHASE2
NCT00831753 Study of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared to Infanrix®Hexa in Healthy Peruvian Infants Status COMPLETED Phase PHASE3
NCT00805389 Study to Compare the Efficacy of GSK Biologicals' Adjuvants in Combination With the Antigen of the Hepatitis B Vaccine Status COMPLETED Phase PHASE2
NCT00792610 The Hepatitis B Vaccine Booster Response Among the Youth Who Had Completed Neonatal Hepatitis B Vaccines Status COMPLETED Phase NA
NCT00782301 Maraviroc Versus Etravirine In Combination With Antiretroviral Therapy In Drug Experienced HIV And Hepatitis Co-Infected Patients Status WITHDRAWN Phase PHASE4
NCT00774995 Immune Response of Healthy Subjects Who Received Neonatal Vaccination Course With Engerix™-B Vaccine. Status COMPLETED Phase PHASE4
NCT00767936 Viral & Host Factors Associated With Hepatitis B Virus-related Hepatocellular Carcinoma Status TERMINATED Phase N/A
NCT00760721 Increasing Hepatitis B Screening Among Korean Church Attendees Status COMPLETED Phase PHASE3
NCT00753649 Immunogenicity and Safety of GSK Biologicals' Infanrix Hexa in Infants Status COMPLETED Phase PHASE4
NCT00753467 A Phase II Study to Determine the Safety and Efficacy of Interferon-gamma in Patients With Chronic Hepatitis B Status UNKNOWN Phase PHASE2